GINGER BROWN: Open Payments
NPI 1316359276 · RAINBOW CITY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$249 in 12 payments from 7 companies in 2025. Trend: 2023 $222 · 2024 $263 · 2025 $249
Food & beverage: $249
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $69 |
| Novo Nordisk Inc | 3 | $63 |
| PFIZER INC. | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 1 | $23 |
| SHIELD THERAPEUTICS INC | 1 | $22 |
| Boston Scientific Corporation | 1 | $20 |
| Amgen Inc. | 1 | $16 |
Products named: Auvelity, NURTEC ODT, FARXIGA, ACCRUFER, General - Pain Management, OTEZLA.
Industry payments across AL — which companies pay providers there.
